Increased preoperative C-reactive protein levels are associated with inhospital death after coronary artery bypass surgery

Inflammation

Volumn 35, Issue 3, 2012, Pages 1179-1183

  De Lorenzo, Andrea ^a,b   Pittella, Felipe ^a   Rocha, Antonio ^a  

^a Dyslipidemia and Atherosclerosis of Ambulatório National Institute of Cardiology   (Brazil)

^b NONE   (Brazil)

Author keywords

C reactive protein; Coronary artery bypass surgery; Coronary artery disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; FEMALE; HAZARD RATIO; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84863792927     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9426-1     Document Type: Article

References (23)

1. Ross, R. 2004. Atherosclerosis is an inflammatory disease: Implications for therapy. The New England Journal of Medicine 9: 2764-2777.
2. Tzoulaki, I., G.D. Murray, A.J. Lee, A. Rumley, G.D. Lowe, and F. G. Fowkes. 2005. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112: 976-983. (Pubitemid 41170265)
3. Ridker, P.M., and N. Cook. 2004. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 109: 1955-1959. (Pubitemid 38544485)
4. Danesh, J., J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G.D. Lowe, et al. 2004. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. The New England Journal of Medicine 350: 1387-1397. (Pubitemid 38419992)
5. Dhingra, R., P. Gona, B.H. Nam, R.B. D'Agostino Sr., P.W. Wilson, E.J. Benjamin, and C.J. O'Donnell. 2007. C-reactive protein, inflammatory conditions, and cardiovascular disease risk. American Journal of Medicine 120: 1054-1062. (Pubitemid 350166233)
6. Lindahl, B., H. Toss, A. Siegbahn, P. Venge, and L. Wallentin. 2000. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. The New England Journal of Medicine 343: 1139-1147.
7. Pearson, T.A., G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, et al. 2003. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511. (Pubitemid 36158056)
8. Gaudino, M., G. Nasso, F. Andreotti, G. Minniti, L. Iacoviello, M. B. Donati, et al. 2002. Preoperative C-reactive protein level and outcome following coronary surgery. European Journal of Cardiovascular Surgey 22: 521-526. (Pubitemid 35286932)
9. Biancari, F., J. Lahtinen, S. Lepojarvi, P. Rainio, E. Salmela, R. Pokela, et al. 2003. Preoperative C-reactive protein and outcomeafter coronary artery bypass surgery. The Annals of Thoracic Surgery 76: 2007-2012. (Pubitemid 37510524)
10. Cappabianca, G., D. Paparella, G. Visicchio, G. Capone, G. Lionettei, F. Numis, et al. 2006. Preoperative C-reactive protein predicts mid-term outcome after cardiac surgery. The Annals of Thoracic Surgery 82: 2170-2178.
11. Kangasniemi, O.P., F. Biancari, Luukkonen, S. Vuorisalo, J. Satta, R. Pokela, et al. 2006. Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery. European Journal of Cardiovascular Surgey 29: 983-985.
12. Kim, D.H., J.K. Shim, S.W. Hong, K.R. Cho, S.Y. Kang, and Y.L. Kwak. 2009. Predictive value of C-reactive protein for major postoperative complications following off-pump coronary artery bypass surgery: Prospective and observational trial. Circulation Journal 73: 872-877.
13. Xu, L., L. Xiao-hui, N. Shao-ping, D. Xin, L. Qiang, K. Jun-ping, et al. 2010. Prognostic value of baseline C-reactive protein levels in patients undergoing coronary revascularization. Chinese Medical Journal 123(13): 1628-1632.
14. Perry, T.E., J.D. Muehlschlegel, K. Liu, A.A. Fox, C.D. Collard, S. C. Body, and CABG Genomics Investigators. 2010. Preoperative C-reactive protein predicts long-term mortality and hospital length of stay after primary, nonemergent coronary artery bypass grafting. Anesthesiology 112: 607-613.
15. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2002. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
16. Currie, C.J., C.D. Poole, and P. Conway. 2008. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 94: 457-462. (Pubitemid 351441401)
17. Hamer, M., Y. Chida, and E. Stamakis. 2010. Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality. Clinical Chemistry 56: 132-135.
18. Bisoendial, R.J., S.M. Boekholdt, M. Vergeer, E.S.G. Stroes, and J. J.P. Kastelein. 2010. C-reactive protein is a mediator of cardiovascular disease. European Heart Journal 31: 2087-2095.
19. Anand, S.A., and S. Yusuf. 2010. C-reactive protein is a bystander of cardiovascular disease. European Heart Journal 31: 2092-2097.
20. Balciunas, M., L. Bagdonaite, R. Samalavicius, L. Griskevicius, and A. Vuylsteke. 2009. Preoperative high-sensitivity C reactive protein predicts coronary events after coronary artery bypass grafting surgery: A prospective observational study. Annals of Cardiac Anaesthesia 12: 127-132.
21. Henriksson, M., S. Palmer, R. Chen, J. Damant, N.K. Fitzpatrick, K. Abrams, et al. 2010. Assessing the cost effectiveness of using prognostic biomarkers with decision models: Case study in prioritising patients waiting for coronary artery surgery. BMJ 340: b5606.
22. Pepys, M.B., G.M. Hirschfield, G.A. Tennent, J.R. Gallimore, M. C. Kahan, V. Bellotti, et al. 2006. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440: 1217-1221.
23. Ridker, P.M., E. Danielson, F.A.H. Fonseca, J. Genest, A.M. Gotto Jr., J.J. Kastelein, et al. 2008. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine 359: 2195-2207.